在延长释放纳尔特雷治疗期间和之后的死亡率,基于两项临床试验的数据
L Gjersing1, L Tanum2, B Weimand3
1Department of Research and Development in Mental Health, Akershus University Hospital, Lørenskog, Norway; Lovisenberg Diaconal University College, Norway; Department of drug and tobacco, Norwegian Institute of Public Health, Oslo, Norway.
Drug and alcohol dependence
|June 21, 2025
概括
延长释放纳尔德 (XR-NTX) 保护阿片类药物使用障碍患者在治疗期间免受过量死亡的危害. 然而,在停止XR-NTX后的一年内,死亡风险显著增加,特别是由于意外中毒.
科学领域:
- 成 药物 药物 药物 药物
- 药理学 药理学是指药理学的学科.
- 公共卫生 公共卫生
背景情况:
- 阿片类药物使用障碍 (OUD) 是一个重大的公共卫生挑战.
- 延长释放纳勒 (XR-NTX) 是FDA批准的用于OUD治疗的药物.
- 了解与XR-NTX治疗相关的死亡风险对于患者管理至关重要.
研究的目的:
- 评估OUD XR-NTX治疗期间和之后的第一年死亡率.
- 确定这种患者群体中死亡的特定原因和风险因素.
主要方法:
- 未来注册研究涉及来自挪威两项临床试验 (2013-2022) 的268名患者.
- 与挪威死亡原因登记处的数据链接.
- 卡普兰-梅尔生存分析和日志等级测试,以比较人口统计和临床子组的死亡率.
主要成果:
- 在XR-NTX治疗期间,只有一个非药物相关的死亡发生.
- 在治疗后的一年里,记录了12例死亡,其中10例归因于意外中毒.
- 总的粗死亡率 (CMR) 为每100人年4.6 (95%CI为2.5-7.5).
结论:
- 在患者正在积极接受治疗时,XR-NTX似乎可以提供对过量死亡的保护.
- 停止使用XR-NTX的患者面临高死亡风险,强调需要持续支持和减少危害策略.
- 意外中毒是XR-NTX停止后死亡的重要原因.
关键词:
禁欲 禁欲 禁欲 禁欲 禁欲药物依赖 药物依赖 药物依赖药物康复 药物康复 药物康复药物治疗 药物治疗延长释放的纳尔特雷克松治疗治疗纳尔特雷克松储存注射,纳尔特雷克松植入物片类药物使用障碍.XR-NTX,阿片类药物成,阿片类药物成更多相关视频
相关概念视频
CNS Depressants: Alcohol and Nicotine
370
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
370
Clinical Trials: Overview
3.4K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.4K
Actuarial Approach
140
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
140
Analgesia and Pain Management
822
Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
822
Phase I Reactions: Reductive Reactions
276
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
276
Clinical Trials
9.3K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
9.3K


